Clinical Trial Update: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining busulfan and cyclophosphamide as a conditioning regimen for hematological malignancies, replacing total body irradiati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Myelomonocytic Leukemia
• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Acute Leukemias, Chronic Leukemias | Phase 4 | Status: UNKNOWN